Hypertension PBMC

About Hypertension PBMC

Hypertension PBMC for Cardiovascular Genomics and Vascular Inflammation Research

Hypertension PBMC samples are collected from IRB-consented donors clinically diagnosed with hypertension (high blood pressure) and processed under controlled conditions within 24 hours of collection. Hypertension itself is a vascular and metabolic disorder — driven by the renin-angiotensin-aldosterone system, sympathetic tone, renal sodium handling, endothelial dysfunction, and vascular remodelling — so these cryopreserved peripheral blood mononuclear cells are supplied for genomic, transcriptomic, and immune-mechanism work rather than as a primary diagnostic assay matrix for blood pressure.

What These Cells Are Used For

  • Genotyping and genetic association work: PBMCs are a convenient, high-quality source of genomic DNA for candidate-gene and genome-wide studies of blood pressure regulation, including RAAS pathway and sodium-handling loci.
  • Transcriptomics: bulk and single-cell RNA sequencing of circulating leukocytes from hypertensive donors, including comparisons across treatment status and comorbidity.
  • Immune contribution to vascular inflammation: the role of T cells, monocytes, and macrophages in vascular and perivascular inflammation is an active area of experimental hypertension research; these donors support translational human work in that area. This is a research hypothesis under investigation, not established clinical diagnostics.
  • Monocyte and T-cell phenotyping by flow cytometry, mass cytometry, or CITE-seq, with paired de-identified clinical metadata.
  • Ex vivo stimulation and functional assays to compare leukocyte responses between hypertensive donors and matched normotensive controls.
  • Epigenetics: DNA methylation and chromatin accessibility profiling in cardiometabolic cohorts.

Donor Stratification Available

  • Essential (primary) versus secondary hypertension
  • Treated versus untreated / treatment-naive donors
  • Antihypertensive drug class: ACE inhibitor, angiotensin receptor blocker, thiazide or thiazide-like diuretic, calcium channel blocker, beta blocker, mineralocorticoid receptor antagonist, or combination therapy
  • Resistant hypertension
  • Comorbid chronic kidney disease, type 2 diabetes, obesity, or dyslipidaemia
  • Established target-organ damage, including left ventricular hypertrophy, prior stroke, or coronary artery disease
  • Matched healthy normotensive controls available

Product Features

  • Research Use Only (RUO), cryopreserved hypertension PBMC samples
  • Clinically confirmed hypertension donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Preserved using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screening (LeukoLot™) available prior to bulk orders

De-identified Donor Data

  • Verified hypertension diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Current medications, including antihypertensive class
  • Self-reported allergies and infectious disease history
  • Additional hypertension-specific clinical data available on request

Applications

  • Genomic DNA extraction and genotyping for blood pressure and cardiometabolic loci
  • Bulk and single-cell transcriptomic profiling of circulating leukocytes
  • Immunophenotyping of monocyte and T-cell subsets in hypertensive versus normotensive donors
  • Research into the immune contribution to vascular and perivascular inflammation
  • Epigenomic profiling, including DNA methylation and ATAC-seq
  • Ex vivo stimulation and cytokine release assays
  • Drug screening and target validation in cardiovascular programmes
  • Proteomic profiling of leukocyte lysates

Other Hypertension Specimen Types

Hypertension donor material is also available as Hypertension Serum, Hypertension Plasma, Hypertension Whole Blood, and Hypertension Leukopak. For serum-based renin, aldosterone, and natriuretic peptide measurements, the serum product is the appropriate matrix.

Compliance and Quality Assurance

  • IRB-approved collections and protocols
  • 21 CFR Part 11-compliant e-consent
  • HIPAA-compliant donor data protection

Ordering & Customization

Hypertension PBMC samples ship on dry ice in standard or custom aliquots. For pricing, international orders, or regulatory documentation, contact learnmore@sanguinebio.com. Browse all human PBMCs or request a custom disease-state collection.

Applications

  • Immunology and translational research
  • Biomarker discovery and validation
  • Drug screening and assay development
  • Vaccine and infectious disease research

Product Features

  • Research Use Only (RUO), PBMC
  • Sourced from screened, consented donors
  • Processed under validated SOPs
  • QC tested for purity, viability, and sterility
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Verified diagnosis and clinical history
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Medication and treatment background when available

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant data management

Ordering & Customization

Human PBMC are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Hypertension PBMC with normal donor samples for comparison

Healthy Donor PBMCs

229 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information